Amgen Inc.
Methods for modulating mannose content of recombinant proteins
Last updated:
Abstract:
The present invention relates to methods of modulating (e.g., reducing) the mannose content, particularly high-mannose content of recombinant glycoproteins.
Status:
Grant
Type:
Utility
Filling date:
10 May 2016
Issue date:
10 Nov 2020